Yatharth Hospital & Trauma Care Services is trading at RS 810.45, up by 39.25 points or 5.09% from its previous close of RS 771.20 on the BSE.

The stock opened at RS 778.35 and recorded a high of RS 819.60 and a low of RS 775.10 so far, with 33,986 shares traded.

The BSE group 'A' stock, with a face value of RS 10, hit a 52-week high of RS 819.60 on September 8, 2025, and a 52-week low of RS 345.35 on March 3, 2025. Over the last week, the stock’s high and low stood at RS 819.60 and RS 765.60 respectively. The company’s current market capitalization is RS 7822.05 crore.

Promoters hold 61.64% of the company, while institutions and non-institutions hold 16.41% and 21.95% respectively.

In a significant expansion move, Yatharth Hospital has signed a strategic agreement to acquire 100% stake in Shantived Institute of Medical Sciences (Shantived Hospital), Agra, for RS 260 crore in an all-cash deal.

Launched in February 2021, Shantived Hospital is a leading multi-speciality healthcare provider in Agra, spread across around 1,65,000 sq. ft. It currently operates about 150 beds with an expandable capacity of 250 beds, is NABH accredited, and empaneled with major insurers and government schemes.

Operating at around 35% occupancy, Shantived Hospital generated revenue of about RS 50 crore in FY2025. Yatharth expects the facility to contribute to its revenue and profit from Day 1 of integration and plans to significantly improve occupancy and operational efficiency to boost growth.

Yatharth Hospital & Trauma Care Services provides comprehensive healthcare services across multiple specialties and super specialties.